APPLIED DNA SCIENCES INC Business Finance Contracts & Agreements
136 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Exchange Agreements (2)
- Guaranty Agreements (1)
- Note Agreements (11)
- Purchase Agreements (18)
- Registration Rights Agreements (10)
- Security Agreements (17)
- Share Agreements (1)
- Stock Agreements (1)
- Subscription Agreements (7)
- Term Sheets (2)
- Trust Agreements (1)
- Underwriting Agreements (9)
- Waiver Agreements (1)
- Warrant Agreements (54)
- Waiver of Negative Covenant (Filed With SEC on October 31, 2024)
- Form of Warrant Amendment (Filed With SEC on October 31, 2024)
- Form of Securities Purchase Agreement, dated October 30, 2024, by and between Applied DNA Sciences, Inc. and the parties thereto (Filed With SEC on October 31, 2024)
- Form of Placement Agent Warrant (Filed With SEC on October 31, 2024)
- Form of Series D Common Stock Purchase Warrant (Filed With SEC on October 31, 2024)
- Form of Series C Common Stock Purchase Warrant (Filed With SEC on October 31, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on October 31, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on May 29, 2024)
- Form of Series B Warrant (Filed With SEC on May 29, 2024)
- Form of Series A Warrant (Filed With SEC on May 29, 2024)
- Form of Placement Agent Warrant (Filed With SEC on May 29, 2024)
- Form of Series B Warrant (Filed With SEC on May 24, 2024)
- Form of Series A Warrant (Filed With SEC on May 24, 2024)
- Form of Series B Warrant (Filed With SEC on May 22, 2024)
- Form of Series A Warrant (Filed With SEC on May 22, 2024)
- Form of Book-Entry Warrant Amendment (Filed With SEC on April 19, 2024)
- Form of Purchase Warrant Amendment (Filed With SEC on April 19, 2024)
- Form of Securities Purchase Agreement, dated January 31, 2024, by and between Applied DNA Sciences, Inc. and the parties thereto (Filed With SEC on February 1, 2024)
- Form of Private Common Warrant (Filed With SEC on February 1, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 1, 2024)
- Equity Distribution Agreement, dated November 7, 2023, by and between Applied DNA Sciences, Inc. and Maxim Group LLC (Filed With SEC on November 7, 2023)
- Share Purchase Agreement, dated July 12, 2023, by and among Spindle Acquisition Corp., Spindle Biotech Inc., the persons listed on Schedule 1.1 therein, Lai Him Chung and Applied... (Filed With SEC on July 13, 2023)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 28, 2023)
- Form of Securities Purchase Agreement, dated August 4, 2022, by and between Applied DNA Sciences, Inc. and certain purchasers (Filed With SEC on August 9, 2022)
- Form of Prefunded Warrant (Filed With SEC on August 9, 2022)
- Form of Series B Warrant (Filed With SEC on August 9, 2022)
- Form of Series A Warrant (Filed With SEC on August 9, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on August 1, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 1, 2022)
- Form of Series B Warrant (Filed With SEC on August 1, 2022)
- Form of Series A Warrant (Filed With SEC on August 1, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on February 23, 2022)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on January 11, 2021)
- Letter Agreement, dated October 9, 2020, by and among Applied DNA Sciences, Inc., Dillon Hill Capital, LLC, and Delaware Trust Company, as Collateral Agent (Filed With SEC on October 14, 2020)
- Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)
- Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 14, 2020)
- Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)
